It could be one of the biggest drug rollouts ever — and test an already burdened system as seniors seek new GLP-1 prescriptions.
Tina Reed is a Senior Health Care Reporter at Axios. She specializes in medicine and healthcare, covering a wide range of topics including pharmaceuticals, wellness programs, and public policy, while also addressing issues related to cybersecurity and consumer packaged goods. Tina's work has been featured in notable publications such as Yahoo News, FierceHealth, and RealClearHealth.

















